DHHS, NIH News  
 
 
National Cancer Institute (NCI)

FOR IMMEDIATE RELEASE
Friday, October 20, 2006


Subscribe
  CONTACT:
NCI Media Relations Branch
301-496-6641

News Advisory

Note To Reporters and Editors:
National Cancer Institute Hosts Session on New Developments in Nanotechnology
What: Please join us to discuss new developments in nanotechnology in cancer. The session will include a review of nanotechnology, how it is affecting research, and accelerating the development of new diagnostics and therapies. Speakers will include NCI leadership, as well as biologists, engineers and physicians who are members of the NCI Alliance for Nanotechnology in Cancer, an initiative to accelerate the application of nanotechnology to cancer research and patient care. Among the featured speakers will be scientists discussing their work in delivery, imaging and therapeutics.
Who: Anna D. Barker, Ph.D. (NCI):NCI Alliance for Nanotechnology in Cancer: Catalyst for Transformation
Thomas A. Kalil (University of California, Berkeley): Nanotechnology Policy Development: Regional and National Initiatives
Sanjiv Gambhir, M.D., Ph.D. (Stanford University): Molecular Imaging in Living Subjects: Shining a New Light on Cancer Diagnostics
Sadik Esener, Ph.D. (University of California, San Diego): Multi-compartment Delivery Vehicles: Novel Approaches for Targeted Therapies
Delivery Vehicles in Targeted Therapies: All Aboard the “Motherships”
James Heath, Ph.D. (California Institute of Technology): Detecting the Impossible: Cancer Candidate Biomarkers and Capture Agents
Scott McNeil, Ph.D. (NCI): Preclinical Characterization of Nanoparticles Intended for Medical Applications
When: Wednesday, October 25, 2006: 12:15-1:30 p.m. PDT
Where: Marina del Rey Room, San Diego Marriott La Jolla
4240 La Jolla Village Drive
La Jolla, California 92037
Directions and map:
http://marriott.com/property/mapandnearbyairports/default.mi?marshaCode=sanlj

If you cannot attend in person, the audio portion of the media session is available to reporters via a toll-free conference line at 866-755-5928, conference ID #9241089. Slides presented during the session can be viewed live, on-line at http://nihbreeze.cit.nih.gov/nanomedia/. To access the slides, use the “enter as guest” option.

The session will begin promptly at 12:15 p.m. PDT. Reporters should dial in and log on 5-10 minutes before the start of the conference. Following the presentations, an operator will inform callers that the session is open to questions. To ask a question, press “*1” on your touchtone phone. You will hear a tone to indicate your question is pending.

For more information on the NCI Alliance for Nanotechnology in Cancer, please visit http://nano.cancer.gov.

For more information about cancer, please visit the NCI Web site at http://www.cancer.gov or call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237).

The National Institutes of Health (NIH) — The Nation's Medical Research Agency — includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.


NIH logo   Home > News & Events
Subscribe to receive future NIH news releases.